Kazia Therapeutics Stock Forecast

Stock Price Forecast

According to 3 analysts polled by S&P Global, Kazia Therapeutics stock has a consensus rating of "Buy" and an average price target of $23.92. The average 1-year stock price forecast is 109.82% higher than the current stock price, while the lowest is $17.63 (+54.65%) and the highest is $29.57 (+159.39%).

Price Target: $23.92 (+109.82%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$17.63	$23.92	$24.57	$29.57
Change	+54.65%	+109.82%	+115.53%	+159.39%

* Price targets were last updated on Apr 15, 2026.

Analyst Ratings

The average analyst rating for Kazia Therapeutics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Oct '25	Nov '25	Dec '25	Jan '26	Apr '26	May '26
Strong Buy	1	1	1	1	1	1
Buy	1	1	1	1	2	2
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	2	2	2	2	3	3

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Yale Jen Laidlaw	Laidlaw	Buy Initiates $25	Buy	Initiates	$25	+119.30%	Apr 15, 2026
Naz Rahman Maxim Group	Maxim Group	Buy Reiterates $20	Buy	Reiterates	$20	+75.44%	Jan 28, 2026
Sean Lee CFA H.C. Wainwright	H.C. Wainwright	Buy Reiterates $18	Buy	Reiterates	$18	+57.89%	Jan 28, 2026

Financial Forecast

Revenue This Year

357.00K

from 1.83M

-80.48%

from 1.83M

Revenue Next Year

117.00K

from 357.00K

-67.23%

from 357.00K

EPS This Year

-0.05

from -

EPS Next Year

n/a

from -0.05

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Jun 30, 2021	Jun 30, 2022	Jun 30, 2023	Jun 30, 2024	Jun 30, 2025	Jun 30, 2026
Revenue	15.18M	10.00K	1,000.00	2.48M	1.83M	357.00K
Revenue Growth	1,436.54%	-99.93%	-90.00%	248,000.00%	-26.28%	-80.48%
Operating Income	-6.38M	-25.38M	-24.15M	-28.46M	-14.22M	-25.01M
Net Income	-8.42M	-25.01M	-20.47M	-26.78M	-20.70M	-25.20M
EPS	-	-	-	-	-	-0.05
Free Cash Flow	1.26M	-16.04M	-14.62M	5.05M	-14.91M	-40.60M
No. Analysts	-	-	-	-	-	2

EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is AUD.

Revenue Forecast

Revenue	2026	2027	2028
High	461,000
Avg	357,000
Low	253,000

Revenue Growth

Revenue Growth	2026	2027	2028
High	-74.8%
Avg	-80.5%
Low	-86.2%

EPS Forecast

EPS	2026	2027	2028
High	-
Avg	-0.05
Low	-

EPS Growth

EPS Growth	2026	2027	2028
High	-
Avg	-
Low	-